Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics (XLO)
NASDAQ:XLO
Xilio Therapeutics (XLO) Financial Statements
52 Followers
Xilio Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -22.65M | $ -22.48M | $ -20.21M | $ -24.55M | $ -21.22M |
| EBITDA | $ -22.15M | $ -21.99M | $ -19.73M | $ -24.11M | $ -20.78M |
| Net Income Common Stockholders | $ -22.65M | $ -22.47M | $ -19.79M | $ -24.61M | $ -21.35M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 93.30M | $ 120.39M | $ 139.14M | $ 159.41M | $ 176.96M |
| Total Assets | $ 111.50M | $ 139.16M | $ 157.41M | $ 178.13M | $ 196.35M |
| Total Debt | $ 18.11M | $ 19.94M | $ 20.10M | $ 20.25M | $ 20.40M |
| Net Debt | $ -75.19M | $ -100.45M | $ -119.05M | $ -139.16M | $ -156.56M |
| Total Liabilities | $ 26.71M | $ 33.52M | $ 31.12M | $ 33.91M | $ 30.23M |
| Stockholders Equity | $ 84.79M | $ 105.65M | $ 126.30M | $ 144.22M | $ 166.12M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -25.42M | $ -18.73M | $ -20.24M | $ -17.53M | $ -21.09M |
| Operating Cash Flow | $ -25.25M | $ -18.22M | $ -19.91M | $ -16.76M | $ -20.84M |
| Investing Cash Flow | $ -170.00K | $ -509.00K | $ -333.00K | $ -771.00K | $ -254.00K |
| Financing Cash Flow | $ -1.69M | $ -21.00K | $ -22.00K | $ -21.00K | $ -5.00K |